Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (512)
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
10,200
Price
$35.08
Total Value
$357.80K
Shares Held After
266,651
% of Holdings
3.7%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
1,686
Price
$38.20
Total Value
$64.41K
Shares Held After
184,558
% of Holdings
0.9%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
8,861
Price
$38.37
Total Value
$340.00K
Shares Held After
186,244
% of Holdings
4.5%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
4,557
Price
$38.37
Total Value
$174.85K
Shares Held After
147,019
% of Holdings
3.0%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
7,301
Price
$38.37
Total Value
$280.14K
Shares Held After
215,426
% of Holdings
3.3%
Liquidia Corp (LQDA)
Schundler Russell — General Counsel
Shares
13,692
Price
$38.37
Total Value
$525.36K
Shares Held After
610,532
% of Holdings
2.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
32,744
Price
$38.37
Total Value
$1.26M
Shares Held After
1,137,599
% of Holdings
2.8%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
18,958
Price
$38.37
Total Value
$727.42K
Shares Held After
405,775
% of Holdings
4.5%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
9,220
Price
$38.37
Total Value
$353.77K
Shares Held After
173,270
% of Holdings
5.1%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
5,101
Price
$38.37
Total Value
$195.73K
Shares Held After
176,918
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$579.53
Total Value
$115.91K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
384
Price
$578.52
Total Value
$222.15K
Shares Held After
40,713
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,475
Price
$577.32
Total Value
$851.54K
Shares Held After
41,097
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,081
Price
$576.36
Total Value
$623.04K
Shares Held After
42,572
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,850
Price
$575.31
Total Value
$1.06M
Shares Held After
43,653
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,370
Price
$574.25
Total Value
$786.72K
Shares Held After
45,503
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,235
Price
$573.39
Total Value
$708.13K
Shares Held After
46,873
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
945
Price
$572.39
Total Value
$540.91K
Shares Held After
48,108
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
925
Price
$571.39
Total Value
$528.53K
Shares Held After
49,053
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
35
Price
$569.78
Total Value
$19.94K
Shares Held After
49,978
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
9,165
Price
$34.97
Total Value
$320.54K
Shares Held After
276,851
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$580.03
Total Value
$23.20K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$579.04
Total Value
$231.62K
Shares Held After
18,916
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
601
Price
$577.93
Total Value
$347.33K
Shares Held After
19,316
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,603
Price
$577.01
Total Value
$924.95K
Shares Held After
19,917
% of Holdings
7.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,354
Price
$575.96
Total Value
$779.84K
Shares Held After
21,520
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,457
Price
$575.06
Total Value
$837.86K
Shares Held After
22,874
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,860
Price
$574.00
Total Value
$1.07M
Shares Held After
24,331
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,210
Price
$572.96
Total Value
$693.28K
Shares Held After
26,191
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,154
Price
$571.76
Total Value
$659.81K
Shares Held After
27,401
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$571.14
Total Value
$160.49K
Shares Held After
28,555
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$569.61
Total Value
$22.78K
Shares Held After
28,836
% of Holdings
0.1%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
33,171
Price
$6.41
Total Value
$212.76K
Shares Held After
49,849
% of Holdings
40.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
3,338
Price
$14.08
Total Value
$47.00K
Shares Held After
421,174
% of Holdings
0.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
15,722
Price
$12.95
Total Value
$203.60K
Shares Held After
424,512
% of Holdings
3.6%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
21,433
Price
$40.12
Total Value
$859.88K
Shares Held After
1,495,234
% of Holdings
1.4%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
23,821
Price
$40.14
Total Value
$956.25K
Shares Held After
411,855
% of Holdings
5.5%
Annexon, Inc. (ANNX)
Carson William H. — Director
Shares
8,000
Price
$6.20
Total Value
$49.60K
Shares Held After
70,405
% of Holdings
11.4%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
500
Price
$34.98
Total Value
$17.49K
Shares Held After
286,016
% of Holdings
0.2%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
6,596
Price
$3.43
Total Value
$22.62K
Shares Held After
515,955
% of Holdings
1.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
400
Price
$13.48
Total Value
$5.39K
Shares Held After
425,512
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
18,660
Price
$12.75
Total Value
$237.91K
Shares Held After
425,912
% of Holdings
4.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
20,000
Price
$74.60
Total Value
$1.49M
Shares Held After
4,398,447
% of Holdings
0.5%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
20,000
Price
$74.60
Total Value
$1.49M
Shares Held After
595,686
% of Holdings
3.2%
Taysha Gene Therapies, Inc. (TSHA)
Nagendran Sukumar — Director
Shares
200,000
Price
$4.46
Total Value
$892.00K
Shares Held After
1,136,410
% of Holdings
15.0%
Ginkgo Bioworks Holdings, Inc. (DNA)
Canton Barry — 10% Owner
Shares
124,727
Price
$6.43
Total Value
$802.49K
Shares Held After
436,422
% of Holdings
22.2%
Ginkgo Bioworks Holdings, Inc. (DNA)
Shetty Reshma P. — Director
Shares
124,727
Price
$6.43
Total Value
$802.49K
Shares Held After
436,422
% of Holdings
22.2%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
3,125
Price
$2.56
Total Value
$8.01K
Shares Held After
29,375
% of Holdings
9.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$573.01
Total Value
$22.92K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$571.68
Total Value
$262.40K
Shares Held After
40,553
% of Holdings
1.1%
Showing 1–50 of 512 transactions (page 1 of 11)